Consensus or Controversy: Clinical Investigators Provide Perspectives on Targeted Treatment of Non-Small Cell Lung Cancer


Consensus or Controversy: Clinical Investigators Provide Perspectives on Targeted Treatment of Non-Small Cell Lung Cancer
Second-line therapy for patient with ALK-rearranged lung cancer after progression on crizotinib?
3:35 minutes.

Clinical Algorithms for Biomarker Testing

Management of Patients with EGFR Tumor Mutations

Management of Patients with ALK and ROS1 Alterations

Identification of Other Potentially Targetable Tumor Mutations